Cutler Group’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Hold
0
1927
2022
Q4
Hold
0
2136
2022
Q3
Sell
-124
Closed -$12K 2265
2022
Q2
$12K Sell
124
-400
-76% -$38.7K ﹤0.01% 1325
2022
Q1
$49K Buy
524
+318
+154% +$29.7K ﹤0.01% 1039
2021
Q4
$17K Buy
206
+163
+379% +$13.5K ﹤0.01% 1524
2021
Q3
$4K Sell
43
-3,557
-99% -$331K ﹤0.01% 1881
2021
Q2
$350K Buy
3,600
+3,000
+500% +$292K 0.02% 534
2021
Q1
$58K Sell
600
-1,407
-70% -$136K ﹤0.01% 1096
2020
Q4
$192K Buy
2,007
+757
+61% +$72.4K 0.01% 574
2020
Q3
$120K Buy
1,250
+850
+213% +$81.6K 0.01% 618
2020
Q2
$48K Buy
+400
New +$48K ﹤0.01% 859
2020
Q1
Hold
0
1846
2019
Q4
Sell
-3,900
Closed -$351K 1915
2019
Q3
$351K Sell
3,900
-4,500
-54% -$405K 0.03% 301
2019
Q2
$709K Buy
8,400
+3,607
+75% +$304K 0.07% 199
2019
Q1
$422K Sell
4,793
-1,950
-29% -$172K 0.04% 277
2018
Q4
$481K Buy
+6,743
New +$481K 0.05% 240
2018
Q3
Hold
0
1995
2018
Q2
Hold
0
2073
2018
Q1
Sell
-24,801
Closed -$1.92M 2245
2017
Q4
$1.92M Sell
24,801
-21,670
-47% -$1.68M 0.08% 139
2017
Q3
$2.85M Buy
46,471
+37,744
+432% +$2.31M 0.11% 108
2017
Q2
$401K Buy
8,727
+7,327
+523% +$337K 0.01% 589
2017
Q1
$60K Sell
1,400
-1,987
-59% -$85.2K ﹤0.01% 1379
2016
Q4
$131K Buy
3,387
+1,187
+54% +$45.9K ﹤0.01% 1056
2016
Q3
$111K Buy
2,200
+1,883
+594% +$95K 0.01% 1060
2016
Q2
$14K Sell
317
-1,519
-83% -$67.1K ﹤0.01% 1969
2016
Q1
$72K Sell
1,836
-4,288
-70% -$168K ﹤0.01% 1100
2015
Q4
$346K Buy
+6,124
New +$346K 0.02% 491